Vanguard Portfolio Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
Vanguard Portfolio Management's WST Position: Q3 2026 in Review
Vanguard Portfolio Management increased its West Pharmaceutical (WST) stake by 2.8% in Q3 2026, buying an estimated $40.4M and bringing the position to 4,130,135 shares worth $1.53B. The position accounts for 0.07% of the portfolio, ranked #311.
Vanguard Portfolio Management first reported a position in WST in Q1 2026 and has held it in 3 quarters since. 881 funds tracked by Wall St. Rank hold WST as of Q3 2026.
- Vanguard Portfolio Management held 4,130,135 shares of West Pharmaceutical worth $1.53B as of Q3 2026.
- Vanguard Portfolio Management bought 114,369 West Pharmaceutical shares in Q3 2026, an estimated $40.4M.
- West Pharmaceutical made up 0.07% of Vanguard Portfolio Management's portfolio in Q3 2026, its #311 holding.
- Vanguard Portfolio Management first reported a position in West Pharmaceutical in Q1 2026 and has held it in 3 quarters since.
- 881 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.
Based on Vanguard Portfolio Management's 13F filing for Q3 2026, filed 13 Nov 2026.